Table 3. Results of EBV antibody and DNA assays.
| EBV DNA | VCA IgM/VCA IgG/EBNA IgG panel | Architect | Liaison | Platelia | |
|---|---|---|---|---|---|
| EBV DNA Positive (N = 74) | −/−/− | Seronegative | 2 | 3 | 8 |
| +/−/− | Early phase acute primary infection | 3 | 0 | 5 | |
| +/+/− | Acute primary infection | 9 | 9 | 0 | |
| +/+/+ | Transient infection/Re-infection | 0 | 1 | 0 | |
| −/+/+ | Past infection | 53 | 49 | 48 | |
| −/+/− | Isolated VCA IgG | 7 | 12 | 10 | |
| −/−/+ | Isolated EBNA IgG | 0 | 0 | 3 | |
| EBV DNA Negative (N = 205) | −/−/− | Seronegative | 37 | 35 | 40 |
| +/−/− | Early phase acute primary infection | 1 | 1 | 0 | |
| +/+/− | Acute primary infection | 0 | 0 | 0 | |
| +/+/+ | Transient infection/Re-infection | 3 | 3 | 0 | |
| −/+/+ | Past infection | 159 | 147 | 144 | |
| −/+/− | Isolated VCA IgG | 5 | 12 | 8 | |
| −/−/+ | Isolated EBNA IgG | 0 | 7 | 13 | |
Abbreviations: EBV, Epstein-Barr virus; VCA, viral capsid antigen; EBNA, Epstein-Barr virus nuclear antigen.